NCT04372654 is a NA clinical trial of Electroducer Sleeve in Coronary Disease, sponsored by Electroducer.

Who is sponsoring NCT04372654?

NCT04372654 is sponsored by Electroducer.

What drugs are being tested in NCT04372654?

Interventions in NCT04372654: Electroducer Sleeve.

What condition does NCT04372654 study?

NCT04372654 studies Coronary Disease, Valve Heart Disease, Pacemaker DDD.

Is NCT04372654 still recruiting?

NCT04372654 is currently completed. Last updated 1 March 2021.

Last reviewed 2021-03-01 · How we verify

NCT04372654

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study Evaluating the Safety of Electroducer Sleeve Medical Device for Temporary Cardiac Stimulation During Percutaneous Cardiovascular Interventions, in All Kind of Patients

Completed NA Last updated 1 March 2021

What this trial tests

NA trial testing Electroducer Sleeve in Coronary Disease in 60 participants. Completed in 22 February 2021.

Timeline

28 July 2020

Primary endpoint
25 January 2021

22 February 2021

Quick facts

Lead sponsor	Electroducer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	60
Start date	28 July 2020
Primary completion	25 January 2021
Estimated completion	22 February 2021
Sites	1 location across France

Drugs / interventions tested

Electroducer Sleeve

Conditions studied

Coronary Disease — all drugs for Coronary Disease →
Valve Heart Disease — all drugs for Valve Heart Disease →
Pacemaker DDD — all drugs for Pacemaker DDD →

Sponsor

Electroducer

Who can join

Adults 18 to 99, any sex, with Coronary Disease or Valve Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During percutaneous cardiovascular intervention, temporary cardiac stimulation may be required. Usually this stimulation is generated via a temporary pacing catheter. In order to reduce the complexity of the procedure, a new stimulation strategy has been developed: the "Direct Wire Pacing technique".In this approach, the cardiac stimulation is provided via the guidewire connected to an external pacemaker. Previous study demonstrated the superiority of the new technique compared to the former. However this technique is likely to generate electrical pain, risk of bleeding for the patient and risk of blood exposure accident for the operators. This is why the medical device ELECTRODUCER SLEEVE has been developed. This device integrates a pacing function to the introducer and the guidewire used. The "Direct Wire Pacing technique" is simplified, secured and more reproducible.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A direct wire pacing device for transcatheter heart valve and coronary interventions: a first-in-human, multicentre study of the Electroducer Sleeve.
Wintzer-Wehekind J, Lefèvre T, Benamer H, Monsegu J, et al · · 2023 · cited 2× · PMID 36484703 · DOI 10.4244/eij-d-22-00662

Verify or expand the search:

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06736899 — Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions · NA · recruiting
NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
NCT07094737 — The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Ca · recruiting
NCT06701968 — Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04372654 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Electroducer
Last refreshed: 1 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04372654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing